WeVote
Log In

Bill

Bill

SB 2870

AN ACT RELATING TO HEALTH AND SAFETY -- LEAD POISONING PREVENTION ACT

2026 Regular Session Introduced by Melissa Murray

Expands routine, no-cost lead screening for children under six and requires licensed labs to report results, improving early detection and data sharing.

06/10/2026 Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 2870

Overview

SB 2870 (Rhode Island, 2026) amends the Lead Poisoning Prevention Act to strengthen screening, testing, reporting, and access to lead analyses for children under six. The bill expands mandatory screening requirements, tightens laboratory certification and reporting, and guarantees no-cost blood lead testing for eligible children.

Purpose and intent

  • Improve identification and monitoring of lead exposure in young children.
  • Ensure consistent screening across healthcare providers, facilities, and state programs.
  • Remove financial barriers to blood lead testing for children under six.
  • Enhance data collection and dissemination to inform case management, hazard reduction, and public awareness.

Key provisions

Screening requirements (Section 23-24.6-7)

  • The Department of Health must promulgate regulations specifying:
    • Means and intervals for lead screening of children under six.
    • Potentially expanding screening to other high-risk groups.
  • Physicians licensed in Rhode Island must screen children under six per the Department’s regulations.
  • Licensed or approved healthcare facilities serving children under six must facilitate screening accordingly.
  • State-funded health programs with child health components must include lead screening per the regulations.
  • Religious exemptions remain: screening can be declined on religious grounds.
  • All blood samples from children under six intended for lead screening must be sent to the Rhode Island State Laboratory or a licensed clinical laboratory in-state for analysis.
  • The Department must annually analyze and summarize screening data for use by local/state agencies, and publish understandable summaries for the healthcare community, the General Assembly, and the public.

Laboratory testing and reporting (Section 23-24.6-21)

  • All clinical and environmental lead analyses must be conducted by laboratories licensed or certified by the Department.
  • Laboratories performing blood lead analyses on children under six must report results to the Department per Department regulations.
  • All such laboratories must provide testing at no cost to the child or parent/guardian, regardless of ability to pay.

Affected parties

  • Children under six years old (primary beneficiaries).
  • Parents/guardians of these children (no-cost testing; religious exemptions noted).
  • Physicians and licensed/registered health care facilities serving pediatric populations.
  • State and local health departments for data analysis and case management.
  • Laboratories performing blood lead analyses (must be properly certified/licensed and provide free testing).

Procedural and timeline aspects

  • Effective date: Upon passage.
  • Regulatory process: Department of Health to promulgate screening and reporting regulations.
  • Annual data analysis: Department to summarize screening data and share with agencies and the public.

Potential impact

  • Standardized, routine lead screening for most children under six, improving early detection.
  • Expanded access to free blood lead testing, reducing financial barriers.
  • Better visibility into lead exposure patterns through annual data reporting.
  • Potential increases in screening costs for providers and facilities offset by state-supported testing and reporting requirements.

If you’d like, I can provide a comparison with current Rhode Island lead screening rules or outline implementation steps for clinics and laboratories.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.